98 related articles for article (PubMed ID: 2523226)
1. Doxacurium chloride: a preliminary clinical trial.
Scott RP; Norman J
Br J Anaesth; 1989 Apr; 62(4):373-7. PubMed ID: 2523226
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function.
Cashman JN; Luke JJ; Jones RM
Br J Anaesth; 1990 Feb; 64(2):186-92. PubMed ID: 2138489
[TBL] [Abstract][Full Text] [Related]
3. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of rapacuronium using edrophonium or neostigmine: pharmacodynamics and pharmacokinetics.
Mills KG; Wright PM; Pollard BJ; Scott JM; Hing JP; Danjoux G; Hunter JM
Br J Anaesth; 1999 Nov; 83(5):727-33. PubMed ID: 10690134
[TBL] [Abstract][Full Text] [Related]
5. Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children.
Bevan JC; Purday JP; Reimer EJ; Bevan DR
Can J Anaesth; 1994 Nov; 41(11):1074-80. PubMed ID: 7828255
[TBL] [Abstract][Full Text] [Related]
6. Neostigmine but not edrophonium prolongs the action of mivacurium.
Symington MJ; Mirakhur RK; Kumar N
Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
[TBL] [Abstract][Full Text] [Related]
7. Train-of-four recovery after pharmacologic antagonism of pancuronium-, pipecuronium-, and doxacurium-induced neuromuscular block in anaesthetized humans.
Stinson LW; Lanier WL; Lennon RL
Acta Anaesthesiol Scand; 1995 Apr; 39(3):406-10. PubMed ID: 7793225
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of doxacurium chloride.
Maddineni VR; Cooper R; Stanley JC; Mirakhur RK; Clarke RS
Anaesthesia; 1992 Jul; 47(7):554-7. PubMed ID: 1385680
[TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacology of doxacurium chloride (BW A938U) in children.
Sarner JB; Brandom BW; Cook DR; Dong ML; Horn MC; Woelfel SK; Davis PJ; Rudd GD; Foster VJ; McNulty BF
Anesth Analg; 1988 Apr; 67(4):303-6. PubMed ID: 2965532
[TBL] [Abstract][Full Text] [Related]
10. A comparison of edrophonium and neostigmine for the antagonism of atracurium-induced neuromuscular block.
Lavery GG; Mirakhur RK; Gibson FM
Anesth Analg; 1985 Sep; 64(9):867-70. PubMed ID: 3161421
[TBL] [Abstract][Full Text] [Related]
11. Dose-response relationships for edrophonium antagonism of mivacurium-induced neuromuscular block during N2O-enflurane-alfentanil anaesthesia.
Marcotte J; Drolet P; Perreault L; Girard M
Can J Anaesth; 1995 Oct; 42(10):879-83. PubMed ID: 8706197
[TBL] [Abstract][Full Text] [Related]
12. Dose-response relations of doxacurium and its reversal with neostigmine in young adults and healthy elderly patients.
Koscielniak-Nielsen ZJ; Law-Min JC; Donati F; Bevan DR; Clement P; Wise R
Anesth Analg; 1992 Jun; 74(6):845-50. PubMed ID: 1534472
[TBL] [Abstract][Full Text] [Related]
13. Comparison of neuromuscular, cardiovascular, and histamine-releasing properties of doxacurium and pipecuronium.
Denman WT; Goudsouzian NG; Gelb C
J Clin Anesth; 1996 Mar; 8(2):113-8. PubMed ID: 8695092
[TBL] [Abstract][Full Text] [Related]
14. Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane.
Goudsouzian NG; Alifimoff JK; Liu LM; Foster V; McNulty B; Savarese JJ
Br J Anaesth; 1989 Mar; 62(3):263-8. PubMed ID: 2522789
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.
Basta SJ; Savarese JJ; Ali HH; Embree PB; Schwartz AF; Rudd GD; Wastila WB
Anesthesiology; 1988 Oct; 69(4):478-86. PubMed ID: 2972233
[TBL] [Abstract][Full Text] [Related]
16. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
Abdulatif M; Al-Ghamdi A; Al-Sanabary M; Abdel-Gaffar ME
Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
[TBL] [Abstract][Full Text] [Related]
17. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
[TBL] [Abstract][Full Text] [Related]
18. Cholinesterase inhibitors do not prolong neuromuscular block produced by mivacurium.
Fleming NW; Lewis BK
Br J Anaesth; 1994 Aug; 73(2):241-3. PubMed ID: 7917744
[TBL] [Abstract][Full Text] [Related]
19. Neostigmine and edrophonium antagonism of moderate neuromuscular block induced by pancuronium or tubocurarine.
Shorten GD; Ali HH; Goudsouzian NG
Br J Anaesth; 1993 Feb; 70(2):160-2. PubMed ID: 8435259
[TBL] [Abstract][Full Text] [Related]
20. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
Fleming NW; Macres S; Antognini JF; Vengco J
Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
